I. A. Gerasimov

I. A. Gerasimov

Auto-generated profile, based on publicly available information

I. A. Gerasimov

National Medical Research Center of Phthisiopulmonology and Infectious Diseases

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Traumatology and Orthopedics of Russia
Verified
Journal Article
Open access
PDF file
EPEvgeny Peretsmanas
Evgeny Peretsmanas
ТТТатьяна Тюлькова
Татьяна Тюлькова
VZVladimir Zubikov
Vladimir Zubikov
IGIlya Gerasimov
Ilya Gerasimov
GKGrigory Kaminsky
Grigory Kaminsky
Background. Osteonecrosis of the femoral head is significantly more common in HIV-positive patients than in the general population. The etiology and pathogenesis of this process are not fully understood. In some studies, suggestions have been made about the possible direct pathological action of the virus on bone tissue cells. No studies dedicated to the identification of the virus directly in the foci of osteonecrosis were found in available literature sources. The aim of the study to present the first clinical cases of patients with aseptic osteonecrosis of the femoral head in whom HIV RNA was found in the focus of bone necrosis. Cases presentation. Patients aged 54 and 38 years, suffering from HIV infection, were admitted to the clinic due to aseptic osteonecrosis of the femoral head. For diagnostic purposes, the patients underwent trephine biopsy of the osteonecrosis sites in the femoral head and unaltered bone tissue of the greater trochanter. The biological material was studied using PCR, microbiological, and histological methods. As a result of the PCR study, HIV RNA was detected in the foci of osteonecrosis in the femoral head. In the blood plasma of both patients, viral load was undetectable. In the bone tissue of the greater trochanter in the 54-year-old patient, the viral load was not determined, while in the 38-year-old patient, the viral load in the greater trochanter was significantly lower than in the necrosis focus of the femoral head. Conclusion. The obtained data may indicate the possibility of direct involvement of the virus in the pathogenesis of arthropathy and cast doubt on the aseptic nature of osteonecrosis in HIV-positive patients.

19 December 2025 in Genij Ortopedii
Verified
Journal Article
Closed access
EPE. O. Peretsmanas
E. O. Peretsmanas
VZV. S. Zubikov
V. S. Zubikov
IGI. A. Gerasimov
I. A. Gerasimov
YRYa. A. Rukin
Ya. A. Rukin
Introduction The fight with nonspecific infection in immunodeficient HIV-infected patients is challenging. There are no standardized treatment protocols yet. The most effective treatment method of purulent coxitis remains two-stage total hip arthroplasty with the first stage of joint resection and implantation of an antibiotic‑loaded cement spacer, and the second stage of total hip replacement. One of the ways to reduce poor results and revision interventions is the development of new types of spacers for treatment of coxitis in patients with HIV infection.The aim of the work is to demonstrate the effectiveness of a new method of surgical treatment of infectious coxitis in HIV-infected patients using an original design of an antibiotic-loaded articulating spacer in two clinical cases. Materials and methods The treatment results of two HIV-positive patients with infectious coxitis, in whom an original two-layer design of an antibiotic-loaded cement spacer based on the individual bacterial sensitivity was applied at the first stage of treatment, were retrospectively evaluated. To study the effectiveness of this method we used the results of the dynamics of pain evaluation according to Visual Analogue Scale (VAS), the functional state of the affected joint using Harris Hip Score (HSS), Western Ontario and McMaster University osteoarthritis Index (WOMAC) scale and radiological data of patients in the early postoperative period and after 12-month follow-up. Results Clinical cases demonstrate positive results of treatment of infectious coxitis associated with HIV infection. Application of the developed spacer design allowed eradication of bacterial infection. As a result of using of the new spacer model with an antimicrobial effect in the first clinical case it was possible to restore the joint function from 35 to 89 HHS points, from 79 to 14 WOMAC points, to reduce the pain syndrome from 7 to 1 VAS point; in the second patient from 32 to 91 HHS points, from 84 to 11 WOMAC points, to reduce the pain syndrome from 6 to 0 VAS points. Discussion Based on scientific reports and our own clinical cases, we hypothesize that in HIV-associated purulent coxitis, one of the main reasons for poor results after two-stage arthroplasty is insufficient local concentration of antimicrobial agents, caused by the imperfect design of traditional cemented spacers. The original spacer design allows for a higher concentration and may become an effective alternative to traditional treatment methods. Conclusion Application of the developed technology of surgical treatment of infectious coxitis in HIV‑positive patients resulted in eradication of infection, reduction of pain syndrome, restoration of the hip joint functionality.

23 September 2021 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
EPE. O. Peretsmanas
E. O. Peretsmanas
IGI. A. Gerasimov
I. A. Gerasimov
VZV. S. Zubikov
V. S. Zubikov
IEI. V. Esin
I. V. Esin
В обзоре проведен анализ публикаций, посвященных экспериментальным исследованиям использования антимикробных препаратов с противотуберкулезной активностью в составе костного цемента. Представлена информация о перспективах использования антимикробных препаратов в составе костного цемента при лечении инфекционных заболеваний суставов.

10 January 2026 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
VZV. S. Zubikov
V. S. Zubikov
IGI. A. Gerasimov
I. A. Gerasimov
EPE. O. Peretsmanas
E. O. Peretsmanas
The objective: to evaluate the use of two-stage arthroplasty in the treatment of a destructive form of septic gonitis of tuberculous and non-specific etiology including HIV-positive patients . Subjects and Methods . 15 patients with a destructive form of septic gonitis of both non-specific and tuberculous etiology were enrolled in the study, all those patients underwent surgical treatment. In 7/15 (46.67%) patients, the disease was caused by M. tuberculosis, in 8 (53.33%) it was a non-specific disease, and 5/15 (33.33%) patients were HIV-positive. The patients were planned to undergo a two-stage endoprosthetics using cemented articulating spacers saturated with antimicrobial drugs, according to the drug susceptibility of the pathogen. 10 patients (66.67%) underwent a full cycle of two-stage endoprosthetics, and 5 cases (33.33%) underwent the first stage only. Results. In all 15 cases, sustained eradication of the infection was achieved. In 10 patients who completed the entire cycle of surgical treatment, a statistically significant improvement in the KSS scores was obtained from 35.4 ± 15.4 to 78.2 ± 15.1 (p<0.05), the observation period ranged from 1 year to 14 years. No significant impact of HIV infection on the treatment results was observed.

18 August 2026 in Genij Ortopedii
Verified
Journal Article
Open access
PDF file
EPE. O. Peretsmanas
E. O. Peretsmanas
VZV. S. Zubikov
V. S. Zubikov
IGI. A. Gerasimov
I. A. Gerasimov
ESE. G. Sokolovich
E. G. Sokolovich
Introduction The first stage of two-step surgery to replace infected hip suggests the intraoperative fabrication of an articulating cement spacer. A critical step is manual holding the metal reinforcement in the mold for 8–12 minutes while the bone cement cures, which increasing the overall surgical time. Optimizing this stage is essential. The objective was to evaluate the effectiveness of the first stage of hip revision in 2-stage surgery optimized with a new device for fixing reinforcement in the manufacture of a cemented spacer for the hip joint. Material and methods A new device (RU Patent No. 232924 U1), made of medical-grade AISI304 stainless steel, which is reusable and sterilizable, allows for the fixation of reinforcement used to manufacture hip articulating spacers in a clamp and their positioning over the center of a mold cell sized to fit the acetabulum (diameters 46–62 mm in 2 mm increments). With the cell filled with cement, the reinforcement was inserted to the specified depth and secured with the device. After 8–12 minutes, to allow polymerization completed, the construct was removed for cementation of the femoral component. A retrospective analysis of 85 patients with infectious coxitis surgically treated between 2023 and 2026 was conducted: the spacer was made by manual retention of reinforcement in the control group (n = 51) and the spacer was made using a new fixation device in the study group (n = 34). Total operative time (min), the frequency of spacer revisions, and early complications were assessed. The groups were comparable for key parameters. Results Operating time was reduced by 13.7 minutes in the study group ((84.5 ± 8.9) min versus (98.2 ± 12.5) min, p = 0.008). The frequency of intraoperative spacer adjustments decreased fivefold (6 % versus 29 %, p = 0.012). No dislocations were recorded early post-op in either group. No significant differences in the accuracy of radiographic parameters (offset, neck-to-shaft angle) were found. Discussion There are no publications reporting similar devices for the fabrication of the acetabular component of the hip articulating spacers. Patients with an underlying infectious process (tuberculous or purulent coxitis) and frequent comorbidities (HIV, hepatitis) may benefit with even a relatively small reduction in surgical time improving the prognosis. The lack of need for spacer modification preserves the integrity of the femoral head surface and ensures a more uniform distribution of the antibiotic in the cement. Conclusion The device offered can be recommended for clinical implementation reducing surgical time by an average of 14 minutes and the frequency of spacer modifications.